Kobiałka, S.; Sędłak, K.; Pelc, Z.; Mlak, R.; Endo, Y.; Bogacz, P.; Kurylcio, A.; Polkowski, W.P.; Pawlik, T.M.; Rawicz-Pruszyński, K.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy. J. Clin. Med. 2024, 13, 161.
https://doi.org/10.3390/jcm13010161
AMA Style
Kobiałka S, Sędłak K, Pelc Z, Mlak R, Endo Y, Bogacz P, Kurylcio A, Polkowski WP, Pawlik TM, Rawicz-Pruszyński K.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy. Journal of Clinical Medicine. 2024; 13(1):161.
https://doi.org/10.3390/jcm13010161
Chicago/Turabian Style
Kobiałka, Sebastian, Katarzyna Sędłak, Zuzanna Pelc, Radosław Mlak, Yutaka Endo, Paweł Bogacz, Andrzej Kurylcio, Wojciech P. Polkowski, Timothy M. Pawlik, and Karol Rawicz-Pruszyński.
2024. "Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy" Journal of Clinical Medicine 13, no. 1: 161.
https://doi.org/10.3390/jcm13010161
APA Style
Kobiałka, S., Sędłak, K., Pelc, Z., Mlak, R., Endo, Y., Bogacz, P., Kurylcio, A., Polkowski, W. P., Pawlik, T. M., & Rawicz-Pruszyński, K.
(2024). Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy. Journal of Clinical Medicine, 13(1), 161.
https://doi.org/10.3390/jcm13010161
